Non-Melanoma Skin Cancer


Evaluation of Oedema and lymphatic function following volumetric modulated arc therapy for non-melanoma extensive skin field cancerisation of the lower limbs.

Trial overview


Non-melanoma Skin Cancer


To evaluate lower limb volume changes using lymphography scans and measurements around the limb receiving standard of care radiotherapy treatment, to monitor swelling experienced in the leg, during and up to 6-months post treatment. The study aims to provide a better understanding of factors which may influence swelling (lymphodema) during radiation treatment.

Eligibility criteria

To be considered for the study you must meet the following criteria:

  • Aged 50 years or older
  • Have symptomatic extensive skin field cancerisation (ESFC) of the lower limb greater than 50cm2  
  • Be undergoing wide field (>50cm2) VMAT radiation therapy at GenesisCare trial sites in NSW

Study details

This study will utilize various assessment measures to observe and monitor any swelling that a patient experience in their leg during your treatment and for 6 months following completion of treatment. We anticipate that this study will give us better understanding of factors which may influence swelling during radiation treatment allowing GenesisCare to continue to provide excellence in patient care.

Further information

This is a GenesisCare sponsored trial that is not registered on ANZCTR or

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.